Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Liver Cirrhosis Treatment Companies

Cirrhosis is a late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcoholism. Liver cirrhosis treatment companies focus on developing, manufacturing, and distributing therapies, medications, and medical interventions designed to manage and address liver cirrhosis. Treatment aims to slow the progression of cirrhosis, manage complications, and improve the overall health of individuals with this condition.

Liver Cirrhosis Treatment Key Companies

Latest Liver Cirrhosis Treatment Companies Update

Intercept Pharmaceuticals (US) Received breakthrough therapy designation from the FDA for their drug Obeticholic Acid (OCA) for the treatment of non-alcoholic steatohepatitis (NASH) with fibrosis.Partnered with research institutions to conduct Phase III clinical trials for OCA in combination with other therapies for advanced liver cirrhosis stages.

Gilead Sciences (US) Launched their antiviral drug Vemlidis® (Tenofovir Alafenamide) for the treatment of chronic hepatitis B infection, potentially preventing progression to cirrhosis in infected individuals.Continued clinical trials for their investigational anti-fibrotic drug GS-4941 as a potential treatment option for liver cirrhosis due to various causes.

Novartis (Switzerland) Initiated Phase II clinical trials for their novel anti-fibrotic drug PBI-454 with promising early results in reducing liver fibrosis in patients with NASH.Collaborated with patient advocacy groups to raise awareness about liver cirrhosis and advocate for improved access to treatment options.

Viking Therapeutics (US) Received Fast Track designation from the FDA for their drug VK5-2377, a potential first-in-class treatment for primary biliary cholangitis, a progressive liver disease that can lead to cirrhosis.Partnering with healthcare providers to develop clinical trial enrollment strategies and expand access to innovative treatment options for liver cirrhosis patients.

World Health Organization (WHO) Launched a global roadmap to eliminate viral hepatitis as a public health threat by 2030, emphasizing prevention, screening, and access to effective treatment for hepatitis B and C.Provided technical assistance and resources to low- and middle-income countries to strengthen their healthcare systems and improve management of liver cirrhosis patients.

List of Liver Cirrhosis Treatment Key Companies in The Market

Pfizer, Inc. (US)

Merck & Co., Inc. (Germany)

Novartis AG (Switzerland)

Hoffmann-La Roche Ltd (Switzerland)

Takeda Pharmaceutical Company Limited (Japan)

Gilead Sciences, Inc. (US)

AstraZeneca (UK)

Bayer AG (Germany)

Sanofi (France)

Shionogi Inc. (Japan)

Promethera (Belgium)

Liver Cirrhosis Treatment Market Highlights:

Liver Cirrhosis Treatment Market Size

Liver Cirrhosis Treatment Market Trends

Liver Cirrhosis Treatment Market Analysis

Liver Cirrhosis Treatment Market Share

Liver Cirrhosis Treatment Market Highlights:

Liver Cirrhosis Treatment Market Trends

Liver Cirrhosis Treatment Market Analysis

Liver Cirrhosis Treatment Market Share

Liver Cirrhosis Treatment Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.